Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on December 1, 2004

Published online before print September 2, 2004
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.0104050v1
76/6/1104    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walrand, S.
Right arrow Articles by Vasson, M-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walrand, S.
Right arrow Articles by Vasson, M-P.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0104050


Received for publication January 29, 2004.
Revised July 15, 2004.
Accepted for publication July 28, 2004.


Article

In vivo evidences that insulin regulates human polymorphonuclear neutrophil functions

S. Walrand *{dagger}@, C. Guillet *, Y. Boirie *, and M-P. Vasson {dagger}

*Unité du Métabolisme Protéino-Energétique, UMR Université d’Auvergne/INRA, and {dagger}Laboratoire de Biochimie, Biologie Moléculaire et Nutrition, EA 2416, Faculté de Pharmacie, Centre de Recherche en Nutrition Humaine, Clermont-Ferrand, France

@ To whom correspondence should be addressed. E-mail: swalrand{at}clermont.inra.fr.


   Abstract

Polymorphonuclear neutrophils (PMNs) are able to destroy invasive mircoorganisms by a wide variety of functions. Whereas insulin does not stimulate hexose transport in PMNs, previous reports have clearly shown that this hormone regulates glucose metabolism inside this cell, raising the question of insulin action on PMN functions in humans. It is interesting that in vitro studies established a strong relationship between specific binding of insulin to its PMN membrane receptor and the activation of the main PMN functions. Therefore, investigation in healthy subjects under strict euglycemia and physiological insulinemia was performed to understand the in vivo-specific action of insulin on PMN functions without hyperglycemia interferences. We determined numerous PMN functions before and after hyperinsulinemia (0.5 mU/kg/min) and euglycemia (0.9 giga/liter) clamp for 4 h in eight adult healthy volunteers (24±6 years). The total number of PMNs and the number of PMNs expressing CD11b, CD15, CD62L, and CD89 were significantly increased over baseline (P<0.001), whereas the density of these receptors was down-regulated (P<0.01) by insulin. PMN chemotaxis (+117%, P<0.05), phagocytosis (+29%, P<0.001), and bactericidal (+17-25%, P<0.001) capacities were increased during the insulin clamp (P<0.05). Therefore, insulin treatment may modulate PMN functions not only by attainment of a better metabolic control, as suggested by in vivo studies in diabetic patients, but also through a direct effect of insulin.

Key Words: PMNs • chemotaxis • phagocytosis • CD expression • reactive oxygen species production







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2004 by the Society for Leukocyte Biology.